You are here: Industry Insights > Orchid Pharma

News List

NCLT approves Dhanuka’s resolution plan for Orchid Pharma expressbpd
June 27, 2019
According to the Dhanuka plan, the creditors will get around Rs 1,116 crore including Rs 570 crore quoted by Dhanuka Lab. Orchid’s liquidation value was around Rs 1,300 crore
Divi’s, Gland, Fidelity enter race to buy Orchid Pharma firstwordpharma
March 04, 2019
The Economic Times reported that Divi's Laboratories, Divi’s Laboratories Gland Celsus Bio Chemicals and Fidelity Trading Corporation have shown preliminary interest in taking over Orchid Pharma.
Orchid Pharma gets EIR from US FDA expressbpd
January 09, 2018
The Chennai facility was recently inspected by US FDA
Orchid Pharma gets EIR from US FDA for its Alathur facility expressbpd
September 25, 2017
Orchid Pharma has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tamil Nadu.
Orchid Pharma receives EIR from US FDA for Tamil Nadu plant financialexpress
April 19, 2017
The report was issued based on the successful inspection of the formulation manufacturing facility at Irungattukottai